Standigm secures $10 million From Pavilion Capital to accelerate its global competitiveness

(Standigm Inc.) " I thank Pavilion Capital for their support to further strengthen Standigm's specialized workflow AI technology in developing first-in-class drug compounds, " said Jinhan Kim, co-founder and CEO of Standigm.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news